Beta-adrenoceptor Polymorphisms

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2003 Dec 3

PMID 14647973

Citations 42

Authors

K Leineweber

R Buscher

H Bruck

O-E Brodde

Affiliations

Soon will be listed here.

Abstract

There can be no doubt that beta(1)-, beta(2)- and beta(3)-adrenoceptor genes have genetic polymorphisms. Two single nucleotide polymorphisms have been described for the beta(1)- (Ser49Gly; Gly389Arg), three for the beta(2)- (Arg16Gly; Gln27Glu; Thr164Ile) and one for the beta(3)-adrenoceptor subtype (Trp64Arg) that might be of functional importance. The possibility that changes in expression or properties of the beta-adrenoceptors due to single nucleotide polymorphisms might have phenotypic consequences influencing their cardiovascular or metabolic function or may contribute to the pathophysiology of several disorders like hypertension, congestive heart failure, asthma or obesity is an idea that has attracted much interest during the last 10 years. At present, it appears that these beta-adrenoceptor polymorphisms are very likely not disease-causing genes, but might be risk factors, might modify disease and/or might influence progression of disease. The aim of this review is to provide an overview of the functional consequences of such beta-adrenoceptor polymorphisms in vitro, ex vivo and in vivo.

Citing Articles

Adrenoceptors in the Eye - Physiological and Pathophysiological Relevance.

Ruan Y, Buonfiglio F, Gericke A Handb Exp Pharmacol. 2023; 285:453-505.

PMID: 38082203 DOI: 10.1007/164_2023_702.

Adrenergic receptors gene polymorphisms and autonomic nervous control of heart and vascular tone.

Matuskova L, Javorka M Physiol Res. 2022; 70(Suppl4):S495-S510.

PMID: 35199539 PMC: 9054179. DOI: 10.33549/physiolres.934799.

Association of gene polymorphisms with women urinary incontinence.

Aniulis P, Podlipskyte A, Smalinskiene A, Aniuliene R, Jievaltas M Open Med (Wars). 2021; 16(1):1190-1197.

PMID: 34514165 PMC: 8389500. DOI: 10.1515/med-2021-0332.

The Association of Trp64Arg Polymorphism in the Beta-Adrenergic Receptor With Insulin Resistance: Meta-Analysis.

Wang H, Zhang C, Li M, Lin Q, Zhang Q, Liu D Front Endocrinol (Lausanne). 2021; 12:708139.

PMID: 34512548 PMC: 8426512. DOI: 10.3389/fendo.2021.708139.

The Role of Adrenoceptors in the Retina.

Ruan Y, Bohmer T, Jiang S, Gericke A Cells. 2020; 9(12).

PMID: 33287335 PMC: 7761662. DOI: 10.3390/cells9122594.

References

Mason D, Moore J, Green S, Liggett S . A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem. 1999; 274(18):12670-4. DOI: 10.1074/jbc.274.18.12670. View

Poller U, Fuchs B, Gorf A, Jakubetz J, Radke J, Ponicke K . Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen. Cardiovasc Res. 1999; 40(1):211-22. DOI: 10.1016/s0008-6363(98)00101-1. View

Scott M, Swan C, P Wheatley A, Hall I . Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene. Br J Pharmacol. 1999; 126(4):841-4. PMC: 1571207. DOI: 10.1038/sj.bjp.0702385. View

White H, Maqbool A, McMahon A, Yates L, Ball S, Hall A . An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy. Eur Heart J. 2002; 23(14):1087-92. DOI: 10.1053/euhj.2001.3037. View

Bray M, Krushkal J, Li L, Ferrell R, Kardia S, Sing C . Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation. 2000; 101(25):2877-82. DOI: 10.1161/01.cir.101.25.2877. View

Kobilka B, Dixon R, Frielle T, Dohlman H, Bolanowski M, Sigal I . cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A. 1987; 84(1):46-50. PMC: 304138. DOI: 10.1073/pnas.84.1.46. View

OShaughnessy K, Fu B, Dickerson C, Thurston D, Brown M . The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond). 2002; 99(3):233-8. View

Weir T, Mallek N, Sandford A, Bai T, Awadh N, Fitzgerald J . beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med. 1998; 158(3):787-91. DOI: 10.1164/ajrccm.158.3.9801035. View

Martin C, Advenier C . Beta 3-adrenoceptors and airways. Fundam Clin Pharmacol. 1995; 9(2):114-8. DOI: 10.1111/j.1472-8206.1995.tb00270.x. View

10.

Liggett S . Polymorphisms of the beta2-adrenergic receptor and asthma. Am J Respir Crit Care Med. 1997; 156(4 Pt 2):S156-62. DOI: 10.1164/ajrccm.156.4.12tac-15. View

11.

Xie H, Stein C, Kim R, Gainer J, Sofowora G, Dishy V . Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans. Clin Pharmacol Ther. 2000; 67(6):670-5. DOI: 10.1067/mcp.2000.106293. View

12.

Walston J, Silver K, Bogardus C, Knowler W, Celi F, Austin S . Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med. 1995; 333(6):343-7. DOI: 10.1056/NEJM199508103330603. View

13.

Kay L, Chong L, Rostami-Hodjegan A, Peachell P . Influence of the thr164ile polymorphism in the beta2-adrenoceptor on the effects of beta-adrenoceptor agonists on human lung mast cells. Int Immunopharmacol. 2003; 3(1):91-5. DOI: 10.1016/s1567-5769(02)00217-5. View

14.

Damato M, Vitiani L, Petrelli G, Ferrigno L, di Pietro A, Trezza R . Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med. 1998; 158(6):1968-73. DOI: 10.1164/ajrccm.158.6.9804126. View

15.

Tonolo G, Melis M, Secchi G, Atzeni M, Angius M, Carboni A . Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J Hypertens. 1999; 17(1):33-8. DOI: 10.1097/00004872-199917010-00006. View

16.

Charon C, DUPUY F, Marie V, Bazin R . Effect of the beta-adrenoceptor agonist BRL-35135 on development of obesity in suckling Zucker (fa/fa) rats. Am J Physiol. 1995; 268(6 Pt 1):E1039-45. DOI: 10.1152/ajpendo.1995.268.6.E1039. View

17.

Wagoner L, Craft L, Zengel P, McGuire N, Rathz D, Dorn 2nd G . Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J. 2002; 144(5):840-6. DOI: 10.1067/mhj.2002.125325. View

18.

Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J . Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol. 2001; 27(2):133-44. DOI: 10.1677/jme.0.0270133. View

19.

Arner P, Hoffstedt J . Adrenoceptor genes in human obesity. J Intern Med. 1999; 245(6):667-72. DOI: 10.1046/j.1365-2796.1999.00495.x. View

20.

Kimura K, Sasaki N, Asano A, Mizukami J, Kayahashi S, Kawada T . Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes. Horm Metab Res. 2000; 32(3):91-6. DOI: 10.1055/s-2007-978597. View